NURIX THERAPEUTICS INC's ticker is NRIX and the CUSIP is 67080M103. A total of 126 filers reported holding NURIX THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,246 | -21.3% | 2,703 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $27,003 | -9.0% | 2,703 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $29,679 | -15.7% | 2,703 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $35,220 | +2.8% | 2,703 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $34,247 | +14.9% | 2,703 | +27.0% | 0.00% | +100.0% |
| Q1 2022 | $29,813 | -88.6% | 2,128 | -76.4% | 0.00% | -75.0% |
| Q4 2021 | $261,100 | -3.4% | 9,019 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $270,209 | +25.0% | 9,019 | +29.8% | 0.00% | +33.3% |
| Q1 2021 | $216,107 | +88.2% | 6,951 | +99.0% | 0.00% | +50.0% |
| Q4 2020 | $114,850 | -5.8% | 3,493 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $121,941 | – | 3,493 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 1,822,883 | $18,210,601 | 1.88% |
| DAFNA Capital Management LLC | 556,695 | $5,561,383 | 1.52% |
| Deep Track Capital, LP | 2,997,830 | $29,948,322 | 1.39% |
| Redmile Group, LLC | 2,857,309 | $28,544,517 | 1.10% |
| WestHill Financial Advisors, Inc. | 283,333 | $2,830,497 | 0.80% |
| Boxer Capital, LLC | 1,224,892 | $12,237 | 0.57% |
| AtonRa Partners | 30,142 | $301,119 | 0.47% |
| Affinity Asset Advisors, LLC | 100,000 | $999,000 | 0.35% |
| HARVARD MANAGEMENT CO INC | 314,762 | $3,144 | 0.31% |
| WASATCH ADVISORS LP | 3,869,775 | $38,659,052 | 0.23% |